Community Research and Development Information Service - CORDIS

Abstract

In order to analyse the social impact of a recombinant pertussis vaccine (Acelluvax), eighty interviews were carried out with paediatricians and families in Italy and Germany, two countries with very different perceived attitudes to biotechnology. The results show that the paediatrician's attitude towards pertussis vaccine is the key factor influencing the social acceptance of a vaccine, although media coverage of vaccine related issues is also important. Support for biotechnology applications in the health care/vaccine area was also found to be much greater than in the agrofood area. To assess the economic impact of recombinant vaccines in-depth interviews were held with industry representatives. The introduction of acellular vaccines has induced significant growth of the pertussis vaccines market, with less significant growth in terms of employment. Analysis has also confirmed that the recombinant pertussis vaccine is the most cost-effective alternative.

Additional information

Authors: CERISS, Centro per l'educazione, la ricerca e l'informazione su scienza e societa (IT);FHG-ISI, Fraunhofer-Institut fur Systemtechnik und Innovationsforschung (DE)
Bibliographic Reference: EUR 18311 EN (1998) 82pp.
Availability: Available from OOPEC Sales agents
ISBN: ISBN 92-828-3935-4
Record Number: 199910497 / Last updated on: 1999-03-26
Category: PUBLICATION
Original language: en
Available languages: en
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top